November 9, 2026 · JACC. Cardiovascular interventions · DOI: 10.1016/j.jcin.2026.08.016

Prevalence and Consequences of Guideline-Directed Indications for Aortic Valve Replacement in the EARLY TAVR Trial.

Listen to this summary

This post hoc analysis of the EARLY TAVR trial asked how often patients with asymptomatic severe aortic stenosis meet ACC/AHA Class II guideline indications for valve replacement at baseline, and whether early TAVR's benefit differs in these patients. About 29% had a Class II indication, and they had higher event rates than those without (24.5% vs 14.5% for death, stroke, or heart failure hospitalization), but the benefit of early TAVR over clinical surveillance was consistent across both groups (interaction P = 0.96). These findings support early TAVR in asymptomatic severe AS regardless of whether Class II guideline indications are present.

Mahesh V Madhavan, Allan Schwartz, Brian R Lindman, Philippe Pibarot, David J Cohen, J Bradley Oldemeyer, Vasilis Babaliaros, William F Fearon, David Daniels, Adnan Chhatriwalla, Clifford J Kavinsky, Pinak Shah, Molly Szerlip, Thom Dahle, Kashish Goel, William O'Neill, Raj Makkar, Charles Davidson, Tej Sheth, Paul Sorajja, James DeVries, Jeffrey Southard, Jeremiah P Depta, Andrei Pop, Rebbecca T Hahn, Yanglu Zhao, Martin B Leon, Philippe Genereux

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play